+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

From
From
From
From
From
From
From
Biologics Contract Development Market Report 2025 - Product Thumbnail Image

Biologics Contract Development Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Biopharmaceutical CMO Market Report 2025 - Product Thumbnail Image

Biopharmaceutical CMO Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
From
mRNA Therapeutics Market Report 2024 - Product Thumbnail Image

mRNA Therapeutics Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
PEGylated Proteins Global Market Report 2024 - Product Thumbnail Image

PEGylated Proteins Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
From
From
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 196 Pages
  • Global
From
Pharmaceutical Filtration - Global Strategic Business Report - Product Thumbnail Image

Pharmaceutical Filtration - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more